Image

Muscle Ultrasound Study in Shock Patients

Recruiting
18 years of age
Both
Phase N/A

Powered by AI

Overview

Intensive Care Unit (ICU) patients are known to lose muscle mass and function for many reasons, ranging from prolonged immobilization, to the effects of ICU treatments such as mechanical ventilation (MV), to the critical illness itself. Ultrasonography (US) is widely used in the ICU setting and has greatly evolved in the last decades, since it allows the non-invasive assessment of different structures, using radiation-free and user-friendly technology; its application for the assessment or the skeletal muscle is a promising tool and might help detecting muscle changes and thus several dysfunctions during early stages of ICU stay.

By using skeletal muscle ultrasound at both diaphragm and peripheral levels, the overall aim of this study is to improve knowledge in the early detection of muscle dysfunction and weakness , and their relationship with mechanical ventilation weaning and muscle strength, in critically ill patients suffering from septic shock.

Eligibility

Inclusion Criteria:

  1. adult patients (> 18 years old) admitted to the ICU
  2. with a diagnosis of septic shock
  3. a SOFA score equal or superior to 8 points, at ICU admission
  4. blood lactate concentration above 2 mmol/L, at ICU admission
  5. expected to have more than 48h of mechanical ventilation (estimated by the attending physician)
  6. expected to stay more than 5 days in the unit (estimated by the attending physician)
  7. able to walk prior to ICU admission / walking aids accepted;

Exclusion Criteria:

  1. pregnancy
  2. lower limb amputation, fixators or open wounds
  3. thoracic fixators or open wounds
  4. diagnosed neuromuscular or central nervous system diseases
  5. being transferred from another ICU
  6. spinal cord injury
  7. diaphragm pacemaker
  8. palliative goals of care
  9. cancers derived sarcopenia
  10. cachexia
  11. anorexic disorders (protein-energy malnutrition)
  12. intellectual or cognitive impairments, limiting the ability to follow instructions.

Study details

Septic Shock

NCT04550143

University Hospital, Geneva

26 January 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.